Is Pfizer Inc. (PFE) a good stock to buy?
Apr 15, 2022 · 20 brokers have issued 12 month target prices for Pfizer's stock. Their forecasts range from $44.00 to $76.00. On average, they expect Pfizer's stock price to reach $58.32 in the next twelve months. This suggests a possible upside of 9.8% from the stock's current price.
How to buy Pfizer stock (PFE)?
102 rows · Pfizer Inc. (PFE) NYSE - Nasdaq Real Time Price. Currency in USD. Add to watchlist. Visitors trend. 2W 10W 9M. Tip: Try a valid symbol or a specific company name for relevant results. 53.12 +0.02 ...
Should I buy Pfizer Inc. (PFE)?
Mar 31, 2022 · According to the issued ratings of 20 analysts in the last year, the consensus rating for Pfizer stock is Buy based on the current 10 hold ratings and 10 buy ratings for PFE. The average twelve-month price target for Pfizer is $58.32 with a high price target of $76.00 and a low price target of $44.00.
Is Pfizer a good stock to buy?
MarketWatch: Stock Market News - Financial News - MarketWatch
Is PFE a buy or sell?
For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.93%2Buy18.44%3Hold9.99%4Sell5.61%2 more rows
Is PFE a buy today?
Citigroup is very positive about PFE and gave it a "$46.00 - $57.00" rating on Apr 05, 2022. The price target was set to 51.24+0.59....Predicted Opening Price for Pfizer Inc of Tuesday, April 19, 2022.Fair opening price April 19, 2022Current price$52.20$51.85 (Undervalued)
How high is PFE stock expected to go?
Stock Price Forecast The 20 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 57.00, with a high estimate of 76.00 and a low estimate of 49.00. The median estimate represents a +13.59% increase from the last price of 50.18.
Is Pfizer stock overvalued?
Is Pfizer Stock Overvalued? Though Pfizer is currently leading the battle against COVID-19, the company is by no means overvalued. In the past five years, its price-to-earnings ratio has gone as low as 11 and as high as 32, averaging 20 for the entire period.
How do I invest in Pfizer?
To buy Pfizer stock, you need to open a brokerage account. A broker serves as an intermediary between you and the stock market, facilitating the purchase and sales of securities like stocks and bonds. If you don't have a brokerage account yet, look for ones that have no trading fees and low investment minimums.Mar 21, 2022
Is Pfizer a private company?
Pfizer would remain a privately held company until June 22, 1942, when 240,000 shares of new common stock were offered to the public.
What is the target price for Moderna?
Stock Price TargetHigh$506.00Low$80.00Average$242.20Current Price$154.75
What is Tesla stock prediction?
Stock Price Forecast The 35 analysts offering 12-month price forecasts for Tesla Inc have a median target of 1,103.00, with a high estimate of 1,580.00 and a low estimate of 67.00. The median estimate represents a +12.32% increase from the last price of 982.05.
What is the forecast for Apple stock?
Stock Price Forecast The 37 analysts offering 12-month price forecasts for Apple Inc have a median target of 191.00, with a high estimate of 215.00 and a low estimate of 145.00. The median estimate represents a +14.07% increase from the last price of 167.44.
Is PFE a good dividend stock?
Pfizer Looks Like A Great Dividend Stock The company is easily earning enough to cover its dividend payments and it is great to see that these earnings are being translated into cash flow. All of these factors considered, we think this has solid potential as a dividend stock.Dec 16, 2021
Is Pfizer stock undervalued?
In our previous Pfizer updates, we mentioned that Pfizer stock is undervalued, and the fall following the underwhelming sales guidance of its Covid-19 products in 2022 can be used as a buying opportunity. PFE stock has now rallied 10% in a month, narrowing the upside potential.Mar 30, 2022
Who owns Pfizer stock?
The Vanguard Group, Inc.Top 10 Owners of Pfizer IncStockholderStakeShares ownedThe Vanguard Group, Inc.7.83%442,214,512SSgA Funds Management, Inc.5.04%284,816,832BlackRock Fund Advisors4.83%272,567,316Capital Research & Management Co....4.19%236,858,4166 more rows
Is Pfizer a buy right now?
19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 9 hold ratings and...
How has Pfizer's stock been impacted by Coronavirus (COVID-19)?
Pfizer's stock was trading at $32.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organiza...
When is Pfizer's next earnings date?
Pfizer is scheduled to release its next quarterly earnings announcement on Tuesday, May 3rd 2022. View our earnings forecast for Pfizer .
How were Pfizer's earnings last quarter?
Pfizer Inc. (NYSE:PFE) released its earnings results on Tuesday, February, 8th. The biopharmaceutical company reported $1.08 EPS for the quarter, b...
How often does Pfizer pay dividends? What is the dividend yield for Pfizer?
Pfizer announced a quarterly dividend on Friday, December 10th. Stockholders of record on Friday, January 28th will be paid a dividend of $0.40 per...
Is Pfizer a good dividend stock?
Pfizer pays an annual dividend of $1.60 per share and currently has a dividend yield of 3.02%. Pfizer has been increasing its dividend for 12 conse...
What guidance has Pfizer issued on next quarter's earnings?
Pfizer issued an update on its FY 2022 earnings guidance on Tuesday, February, 22nd. The company provided EPS guidance of $6.350-$6.550 for the per...
What price target have analysts set for PFE?
19 Wall Street analysts have issued twelve-month target prices for Pfizer's stock. Their forecasts range from $44.00 to $76.00. On average, they an...
Who are Pfizer's key executives?
Pfizer's management team includes the following people: Dr. Albert Bourla D.V.M. , DVM, Ph.D., Chairman & CEO (Age 60, Pay $7.99M) Mr. Frank A....
What is Pfizer's consensus rating and price target?
According to the issued ratings of 19 analysts in the last year, the consensus rating for Pfizer stock is Buy based on the current 9 hold ratings a...
Do Wall Street analysts like Pfizer more than its competitors?
Analysts like Pfizer stock less than the stock of other Medical companies. The consensus rating score for Pfizer is 2.53 while the average consensu...
Do MarketBeat users like Pfizer more than its competitors?
MarketBeat users like Pfizer stock more than the stock of other Medical companies. 71.75% of MarketBeat users gave Pfizer an outperform vote while...
Is Pfizer being upgraded by Wall Street analysts?
Over the previous 90 days, Pfizer's stock had 1 upgrade by analysts.
Does Pfizer's stock price have much upside?
According to analysts, Pfizer's stock has a predicted upside of 11.17% based on their 12-month price targets.
What analysts cover Pfizer?
Pfizer has been rated by Bank of America , Barclays , BMO Capital Markets , Cowen , JPMorgan Chase & Co. , Mizuho , Morgan Stanley , Sanfor...
About Pfizer
Pfizer (NYSE:PFE) Frequently Asked Questions
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
What is Pfizer's consensus rating and price target?
12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last twelve months. There are currently 10 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Pfizer stock.
Do Wall Street analysts like Pfizer more than its competitors?
According to the issued ratings of 12 analysts in the last year, the consensus rating for Pfizer stock is Hold based on the current 10 hold ratings and 2 buy ratings for PFE. The average twelve-month price target for Pfizer is $43.08 with a high price target of $49.00 and a low price target of $39.00. Learn more#N#on PFE's analyst rating history
Do MarketBeat users like Pfizer more than its competitors?
Analysts like Pfizer stock less than the stock of other Medical companies. The consensus rating for Pfizer is Hold while the average consensus rating for medical companies is Buy. Learn more#N#on how PFE compares to other companies
Does Pfizer's stock price have much upside?
MarketBeat users like Pfizer stock more than the stock of other Medical companies. 72.66% of MarketBeat users gave Pfizer an outperform vote while medical companies recieve an average of 67.17% outperform votes by MarketBeat users.
What analysts cover Pfizer?
According to analysts, Pfizer's stock has a predicted upside of 6.74% based on their 12-month price targets.
What is Pfizer Inc?
Pfizer has been rated by Berenberg Bank, Mizuho, Morgan Stanley, Royal Bank of Canada, SVB Leerink, The Goldman Sachs Group, and Truist in the past 90 days.
What is Pfizer's business?
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.
Pfizer Inc. (PFE)
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Style Scorecard
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Chart for PFE
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
